Esperion Therapeutics
ESPR
#6202
Rank
โ‚น78.39 B
Marketcap
โ‚น330.70
Share price
-1.35%
Change (1 day)
67.14%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: โ‚น78.39 Billion

As of December 2025 Esperion Therapeutics has a market cap of โ‚น78.39 Billion. This makes Esperion Therapeutics the world's 6202th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น78.39 B103.43%
2024โ‚น38.53 B36.15%
2023โ‚น28.30 B-25.48%
2022โ‚น37.98 B67.6%
2021โ‚น22.66 B-54.01%
2020โ‚น49.27 B-57.86%
2019โ‚น116.92 B35.52%
2018โ‚น86.28 B-21.66%
2017โ‚น110.13 B473.95%
2016โ‚น19.18 B-42.39%
2015โ‚น33.30 B-36.12%
2014โ‚น52.14 B300.4%
2013โ‚น13.02 B

End of Day market cap according to different sources

On Dec 16th, 2025 the market cap of Esperion Therapeutics was reported to be:

โ‚น80.14 Billion
by Nasdaq info icon info icon
โ‚น79.47 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ultragenyx Pharmaceutical
RARE
โ‚น288.15 B 267.55%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น898.85 B 1,046.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น12.892 T 16,344.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น7.186 T 9,067.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น305.68 B 289.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚น38.41 B-51.00%๐Ÿ‡บ๐Ÿ‡ธ USA